Inari Medical Inc (NARI) stock has fallen -32.68% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NARI stock a score of 32 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 8. NARI’s rank also includes a short-term technical score of 33. The fundamental score for NARI is 56. In addition to the average rating from Wall Street analysts, NARI stock has a mean target price of $107.67. This means analysts expect the stock to increase 86.43% over the next 12 months.
What’s Happening with NARI Stock Today
Inari Medical Inc (NARI) stock is down -3.14% while the S&P 500 is higher by 0.18% as of 10:39 AM on Friday, May 20. NARI has fallen -$1.87 from the previous closing price of $59.62 on volume of 134,621 shares. Over the past year the S&P 500 is down -6.04% while NARI has fallen -32.68%. NARI lost -$0.02 per share in the over the last 12 months. Click Here to get the full Stock Report for Inari Medical Inc stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy
